Search
Movember
About UsProstate CancerResearchIn The NewsGet InvolvedDonate

In The News

CIBC commits $150,000 to Prostate Cancer Canada
Funds going to Canadian BRCA 1/2 Prostate Cancer Network that will collect data on male carriers of the BRCA1 and BRCA2 gene mutations who are at risk of aggressive prostate cancer.  

RSM Richter commits $150,000 to Prostate Cancer Canada
Funds to support innovative Canadian BRCA 1/2 Prostate Cancer Network and the fight against the most common cancer to afflict Canadian men.  

Click For Information Archive

Newsletter

Join our mailing list, receive updates about the Foundation and be the first to find out what's new.
 
 
 
Print this page.  Bookmark this page.  Decrease font size. Increase font size. Reset font size.


Missing gene makes prostate cancer more aggressive

2/24/2010

Research suggests that prostate cancer is more likely to spread and become more aggressive if a specific gene known as DAB2IP quits functioning.
 
 

New research gathered from researcher at UT Southwestern Medical Center suggests that prostate cancer is more likely to spread and become more aggressive if a specific gene known as DAB2IP quits functioning.

Studies have found that various prostate cancer cells can be held in check by the DAB2IP cell, and that when this gene is involved, it prevents other proteins that are present in the development of prostate cancer from becoming over-active.

When the DAB2IP gene stops functioning normally and cells lose this gene, they are able to break free and begin to metastasize and spread to other areas of the body, thus increasing the risk that the cancer will spread to other areas of the body – other organs, lymph system and/or bloodstream.

The study which was published in the Proceedings of the National Academy of Sciences, found that when DAB2IP was eliminated from human carcinoma cells it caused them to change to mesenchymal cells – a sign of metastatic cancer. Cells that have undergone this change have the ability to move easily throughout the body – when the gene is restored it seems as though it reverses the ability to metastasize. Researchers believe that by identifying this gene it can act as a bio-marker aiding physicians in identifying patients with aggressive prostate cancer.

View a complete abstract of this article in
Proceedings of the National Academy of Science.

 
 

Visit our YouTube channel and watch our video compliation of this year's Toronto Father's Day Walk/Run http://tinyurl.com/2dfmmdr

FREE PSA Testing at the #RogersCup in #Toronto! If you're a male over 40, visit the PCC testing area for a free #PSA blood test.

Men NEED to know about treatment options. RT @Reuters_Health: Low-risk prostate cancer treated aggressively http://link.reuters.com/der79m

Click here to visit our
Twitter feed and subscribe
Movember Ther-MO-meter Watch the Mo money grow daily, thanks to Mo Bros and Mo Sistas across Canada. Visit the Movember website for more updates. Current donations: $7 Million
Visit our YouTube channel and watch our video compliation of this year's Toronto Father's Day Walk/Run http://tinyurl.com/2dfmmdr
Follow Us On Twitter
Receive updates and be the first to find out what's new at PCC.
Prostate Cancer Canada
145 Front Street East, Suite 306, Toronto
Ontario M5A 1E3, Canada
info@prostatecancer.ca

Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325
© 2010 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development Inorbital